Cystic fibrosis: ultrastructural changes of nasal mucosa
- PMID: 17643257
- DOI: 10.1007/s00405-007-0393-y
Cystic fibrosis: ultrastructural changes of nasal mucosa
Abstract
Cystic fibrosis (CF) is an inherited multisystemic disorder that results in a generalized dysfunction of exocrine glands. Besides chronic obstructive pulmonary diseases, chronic sinusitis, nasal polyposis and hypertrophy of the inferior turbinates with nasal airway obstruction are typical signs. Tissue samples of the inferior turbinates and nasal polyps were taken during nasal surgery from 21 children, ranging from 3 to 16 years of age. Light- and electron microscopical examination were carried out. Furthermore, specimens of nasal mucosa of patients without chronic inflammation as controls and specimens of duodenal mucosa of patients with CF were investigated. Under a thick layer of respiratory epithelium with a high proportion of goblet cells, the seromucous glands display abnormal morphological structures with wide mucous cells and cystic dilatation. The glandular cells show inhomogeneous glandular droplets in the supranuclear cell portion. The nucleus contains dispersed chromatin as a sign of increased activity and the structures of the Golgi apparatus are clearly detectable. Apart from investigations concerning nasal polyps in CF, studies on the different morphological changes of nasal mucosa at the electron microscopic level are rare. This histological study focuses on various morphological changes of nasal glands at the ultrastructural level in correlation with typical symptoms in CF. In addition, a comparison with electron microscopic findings of CF-enteropathies is proposed. These findings could help to bring information concerning new morphological aspects in the pathophysiology of patients with CF.
Similar articles
-
Pathogenesis and management of nasal polyposis in cystic fibrosis.Curr Allergy Asthma Rep. 2012 Apr;12(2):163-74. doi: 10.1007/s11882-012-0250-y. Curr Allergy Asthma Rep. 2012. PMID: 22350539 Review.
-
[Morphological changes of nasal and duodenal mucosa in patients with cystic fibrosis].Laryngorhinootologie. 2002 Feb;81(2):93-7. doi: 10.1055/s-2002-23109. Laryngorhinootologie. 2002. PMID: 11914945 German.
-
Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis.Am J Rhinol Allergy. 2011 Nov-Dec;25(6):e251-4. doi: 10.2500/ajra.2011.25.3726. Am J Rhinol Allergy. 2011. PMID: 22185734
-
Histology of nasal polyps of different etiology.Rhinology. 1977 Sep;15(3):121-8. Rhinology. 1977. PMID: 905718
-
Rhinological aspects of cystic fibrosis.Monaldi Arch Chest Dis. 2000 Dec;55(6):475-7. Monaldi Arch Chest Dis. 2000. PMID: 11272634 Review.
Cited by
-
Pathogenesis and management of nasal polyposis in cystic fibrosis.Curr Allergy Asthma Rep. 2012 Apr;12(2):163-74. doi: 10.1007/s11882-012-0250-y. Curr Allergy Asthma Rep. 2012. PMID: 22350539 Review.
-
Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair.FASEB J. 2016 Sep;30(9):3011-25. doi: 10.1096/fj.201500166R. Epub 2016 May 13. FASEB J. 2016. PMID: 27178322 Free PMC article.
-
Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.AAPS PharmSciTech. 2014 Jun;15(3):601-11. doi: 10.1208/s12249-014-0084-0. Epub 2014 Feb 21. AAPS PharmSciTech. 2014. PMID: 24557773 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical